✦ LIBER ✦

Attempted treatment of fulminant viral hepatitis with human fibroblast interferon

✍ Scribed by F. Milazzo; G. M. Vigevani; M. Almaviva; M. Galli; R. Esposito; A. Lazzarin; F. Caredda; P. Crocchiolo; M. Moroni; A. Cargnel; M. C. Perna; P. G. Fassio; G. Gavazzeni; A. Pugliese; P. A. Tovo

Publisher: Springer-Verlag
Year: 1985
Tongue: English
Weight: 576 KB
Volume: 13
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01642872

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with human gamma interferon of

Treatment with human gamma interferon of chronic hepatitis B: Comparative study with alpha interferon

✍ Shinichi Kakumu; Tetsuya Ishikawa; Masashi Mizokanii; Etsuro Orido; Kentaro Yosh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

## Abstract A pilot study was designed to determine the tolerance and effectiveness of natural or recombinant gamma interferon in patients with chronic hepatitis B. Sixteen patients received 0.5 to 3.0 million units (MU) per day of gamma interferon (IFN‐γ) for 7 days. Nineteen chronic hepatitis B p

Interferon-α therapy combined with nonst

Interferon-α therapy combined with nonsteroid antiinflammatory drugs for treatment of chronic viral hepatitis?

✍ Pietro Andreone; Carmela Cursaro; Giovanni Gasbarrini 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

Systematic review and meta-analysis of i

Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis

✍ S. Breitenstein; D. Dimitroulis; H. Petrowsky; M. A. Puhan; B. Müllhaupt; P.-A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## Background A combined antiviral and tumoricidal effect of interferon (IFN) is assumed to occur after resection or ablation of hepatocellular carcinoma (HCC). ## Methods An electronic search of the Medline, Embase and Central databases from January 1998 to October 2007 was conducte

Treatment of chronic hepatitis C with ci

Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha

✍ Margarita Pardo; Inmaculada Castillo; Sonia Navas; Dr. Vicente Carreño 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

Interferon therapy in cirrhotic patients with hepatitis C virus infection is not efficient. In an at- tempt t o improve the response rate, a pilot study using recombinant human granulocyte colonystimulating factor (rhG-CSF) alone, and in combination with recombinant interferon-alpha (rlFN), was carr

Efficacy of human leukocyte interferon-α

Efficacy of human leukocyte interferon-α treatment in elderly patients with hepatitis-C virus-related chronic liver disease

✍ A. Cattoni; C. Romano; A. Cecere; R. Caiazzo; P. Grima; P. Altucci 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 465 KB

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial

✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels